CD137: A checkpoint regulator involved in atherosclerosis
- 1 May 2018
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 272, 66-72
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- CD137 Is Induced by the CD40 Signal on Chronic Lymphocytic Leukemia B Cells and Transduces the Survival Signal via NF-κB ActivationPLOS ONE, 2013
- Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisJournal of Clinical Investigation, 2013
- CD137 deficiency does not affect development of airway inflammation or respiratory tolerance induction in murine modelsClinical and Experimental Immunology, 2012
- Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T CellsCancer Research, 2012
- Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosisJournal of Experimental Medicine, 2009
- The role of TNF superfamily members in T-cell function and diseasesNature Reviews Immunology, 2009
- T-Cell Costimulation and Coinhibition in AtherosclerosisCirculation Research, 2008
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIKNature Immunology, 2008
- Role of endogenous 4‐1BB in the development of systemic lupus erythematosusImmunology, 2007
- Inflammation, Atherosclerosis, and Coronary Artery DiseaseNew England Journal of Medicine, 2005